MA19783A1 - Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines. - Google Patents

Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines.

Info

Publication number
MA19783A1
MA19783A1 MA20003A MA20003A MA19783A1 MA 19783 A1 MA19783 A1 MA 19783A1 MA 20003 A MA20003 A MA 20003A MA 20003 A MA20003 A MA 20003A MA 19783 A1 MA19783 A1 MA 19783A1
Authority
MA
Morocco
Prior art keywords
benzoazacycloalkyl
imidazolidines
spiro
preparation
Prior art date
Application number
MA20003A
Other languages
English (en)
Inventor
Malen Charles
Duhault Jacques
Peglion Jean-Louis
Boulanger Michelle
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of MA19783A1 publication Critical patent/MA19783A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MA20003A 1982-04-27 1983-04-27 Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines. MA19783A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8207203A FR2525603A1 (fr) 1982-04-27 1982-04-27 Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
MA19783A1 true MA19783A1 (fr) 1983-12-31

Family

ID=9273425

Family Applications (1)

Application Number Title Priority Date Filing Date
MA20003A MA19783A1 (fr) 1982-04-27 1983-04-27 Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines.

Country Status (22)

Country Link
JP (1) JPS5910584A (fr)
KR (1) KR840004428A (fr)
AT (1) ATA125383A (fr)
AU (1) AU1395383A (fr)
BE (1) BE896572A (fr)
DD (1) DD209833A5 (fr)
DE (1) DE3315106A1 (fr)
DK (1) DK183583A (fr)
ES (1) ES521895A0 (fr)
FR (1) FR2525603A1 (fr)
GB (1) GB2133401B (fr)
GR (1) GR78481B (fr)
IL (1) IL68497A0 (fr)
IT (1) IT1167123B (fr)
LU (1) LU84770A1 (fr)
MA (1) MA19783A1 (fr)
NL (1) NL8301476A (fr)
NO (1) NO831473L (fr)
OA (1) OA07412A (fr)
PT (1) PT76595B (fr)
SE (1) SE8302347L (fr)
ZA (1) ZA832927B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US4927831A (en) * 1988-10-20 1990-05-22 American Home Products Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
EP2189448B1 (fr) 2003-06-17 2014-01-29 Arena Pharmaceuticals, Inc. Procédés de séparation de racemates de 3-Benzazepines
CN101792417A (zh) 2003-06-17 2010-08-04 艾尼纳制药公司 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物
KR101281919B1 (ko) 2004-12-21 2013-07-03 아레나 파마슈티칼스, 인크. (r)-8-클로로-1-메틸-2,3,4,5-테트라히드로-1h-3-벤즈아제핀 히드로클로라이드의 결정질 형태
PT1833473E (pt) 2004-12-23 2009-12-17 Arena Pharm Inc Composições de modulador de receptor 5ht2c e métodos de utilização
EP2001852A2 (fr) 2006-04-03 2008-12-17 Arena Pharmaceuticals, Inc. Procédés de préparation de 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine et produits intermédiaires associés
CA2670285A1 (fr) 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Procedes de preparation de (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine et intermediaires de celle-ci
JP5491421B2 (ja) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストである(r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンに関連する中間体の調製のためのプロセス
CN102648170A (zh) 2009-06-18 2012-08-22 艾尼纳制药公司 制备5-ht2c受体激动剂的方法
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
EP2939677A1 (fr) 2010-09-01 2015-11-04 Arena Pharmaceuticals, Inc. Administration de lorcasérine à des individus avec une insuffisance rénale
CN103189360A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 5-ht2c激动剂的非吸湿性盐
ES2704455T3 (es) 2010-09-01 2019-03-18 Arena Pharm Inc Formas farmacéuticas de liberación modificada de agonistas de 5-HT2C útiles para la gestión del peso
WO2012030938A1 (fr) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Sels de lorcasérine dotés d'acides optiquement actifs
AU2012392187B2 (en) 2012-10-09 2018-07-12 Arena Pharmaceuticals, Inc. Method of weight management

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209630A (en) * 1976-10-18 1980-06-24 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
ES8405796A1 (es) 1984-06-16
SE8302347L (sv) 1983-10-28
IT1167123B (it) 1987-05-13
ES521895A0 (es) 1984-06-16
GB2133401A (en) 1984-07-25
DK183583D0 (da) 1983-04-26
PT76595B (fr) 1986-01-21
DD209833A5 (de) 1984-05-23
ATA125383A (de) 1986-05-15
KR840004428A (ko) 1984-10-15
LU84770A1 (fr) 1984-11-28
JPS5910584A (ja) 1984-01-20
PT76595A (fr) 1983-05-01
SE8302347D0 (sv) 1983-04-26
IL68497A0 (en) 1983-07-31
OA07412A (fr) 1984-11-30
NL8301476A (nl) 1983-11-16
ZA832927B (en) 1984-06-27
AU1395383A (en) 1983-11-03
IT8348155A0 (it) 1983-04-26
NO831473L (no) 1983-10-28
FR2525603B1 (fr) 1984-09-14
GB8311508D0 (en) 1983-06-02
DK183583A (da) 1983-10-28
GB2133401B (en) 1985-10-23
BE896572A (fr) 1983-10-26
DE3315106A1 (de) 1983-11-03
GR78481B (fr) 1984-09-27
FR2525603A1 (fr) 1983-10-28

Similar Documents

Publication Publication Date Title
FI841522A (fi) Processtyrsystem med felsoekning.
FR2479187B1 (fr) Procede de preparation de n-octadienol
RO81944A (fr) Procede de preparasiton des imidosulfamides
FR2527615B1 (fr) Procede de preparation du 26,26,26,27,27,27-hexafluoro-1a,25-dihydroxycholesterol
MA19783A1 (fr) Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines.
FR2532318B1 (fr) Procede de preparation de triarylphosphines sulfonees
MA19925A1 (fr) Procede de preparation de 3-aryl-7chloro-3, 4-dihydroacridine-1, 9-(2H-10H)-dione-1-oxines et -1-hydrazones
FR2555575B1 (fr) Procede de preparation de 4-alcoxyanilines
FR2524316B1 (fr) Procede de photodecontamination
FR2562070B1 (fr) Procede de preparation de 2-amino-s-triazines
FR2525219B1 (fr) Procede pour la preparation de 4-hydroxy-2-methyl-2h-1,2-benzothiazine-3-carboxamide-1-1-dioxydes
FR2496660B1 (fr) Procede de preparation de n-acylcarnosine
BE889546A (fr) Procede de preparation de n-cyclohexylbenzothiazole-2-sulfenamide
FR2534905B1 (fr) Procede de preparation de phenylcetones
PT74559A (fr) Procede de preparation de trifluoromethylphenyl-tetrahydropyri-dines substituees
FR2549039B1 (fr) Procede de preparation de 3,3,3-trifluoro-2-trifluoro-mehylpropene
FR2550190B1 (fr) Procede de preparation de b-phenylserine
FR2528825B1 (fr) Procede de preparation de meta-chlorobenzotrifluorure
FR2527202B1 (fr) Procede de preparation d'ethers tert.butyl-alkyliques
BE896599A (fr) Procede perfectionne de preparation de l-lysine.
FR2527603B1 (fr) Procede catalytique de preparation de thio-bis-phenols
RO81430A (fr) Procede de preparation des azolul siliglycolethers
FR2529889B1 (fr) Procede de preparation des indoles
FR2521556B1 (fr) Procede de preparation de 3, 3'-diamino-diphenylsulfones
FR2493310B1 (fr) Procede de preparation de thymosine a1